RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 75 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,909,766 | +72.1% | 868,474 | +23.8% | 0.00% | +100.0% |
| Q2 2023 | $11,568,296 | -53.6% | 701,534 | -49.8% | 0.00% | 0.0% |
| Q1 2023 | $24,934,040 | +10.8% | 1,397,648 | +80.8% | 0.00% | -50.0% |
| Q4 2022 | $22,510,575 | -33.0% | 773,028 | -43.6% | 0.00% | -50.0% |
| Q3 2022 | $33,588,000 | +1352.8% | 1,370,948 | +146.1% | 0.00% | – |
| Q2 2022 | $2,312,000 | -63.8% | 556,994 | +0.6% | 0.00% | -100.0% |
| Q1 2022 | $6,381,000 | +17.0% | 553,867 | +1.4% | 0.00% | – |
| Q4 2021 | $5,452,000 | +401.1% | 546,320 | +556.0% | 0.00% | – |
| Q3 2021 | $1,088,000 | -33.3% | 83,278 | 0.0% | 0.00% | – |
| Q2 2021 | $1,631,000 | -7.9% | 83,278 | 0.0% | 0.00% | – |
| Q1 2021 | $1,771,000 | +26.2% | 83,278 | +76.5% | 0.00% | – |
| Q4 2020 | $1,403,000 | +6.9% | 47,178 | -22.1% | 0.00% | – |
| Q3 2020 | $1,313,000 | -74.0% | 60,598 | -73.2% | 0.00% | -100.0% |
| Q2 2020 | $5,042,000 | +46.5% | 226,078 | 0.0% | 0.00% | – |
| Q1 2020 | $3,441,000 | -85.4% | 226,078 | -78.0% | 0.00% | -100.0% |
| Q4 2019 | $23,552,000 | +2.9% | 1,025,790 | -3.3% | 0.00% | 0.0% |
| Q3 2019 | $22,892,000 | -13.1% | 1,060,319 | -11.5% | 0.00% | 0.0% |
| Q2 2019 | $26,356,000 | -39.5% | 1,198,019 | -24.6% | 0.00% | -40.0% |
| Q1 2019 | $43,568,000 | -4.1% | 1,589,507 | -5.9% | 0.01% | -16.7% |
| Q4 2018 | $45,427,000 | -4.2% | 1,690,007 | +4.0% | 0.01% | +20.0% |
| Q3 2018 | $47,395,000 | -17.0% | 1,624,794 | -11.0% | 0.01% | -28.6% |
| Q2 2018 | $57,069,000 | +121.3% | 1,825,634 | +40.9% | 0.01% | +133.3% |
| Q1 2018 | $25,786,000 | -31.9% | 1,295,800 | -0.5% | 0.00% | -25.0% |
| Q4 2017 | $37,854,000 | – | 1,302,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |